Market Closed -
Japan Exchange
11:30:00 09/05/2024 am IST
|
5-day change
|
1st Jan Change
|
2,567
JPY
|
+2.80%
|
|
+2.97%
|
-16.66%
|
Fiscal Period: März |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
28,592
|
35,502
|
35,597
|
52,670
|
59,673
|
56,161
|
-
|
-
|
Enterprise Value (EV)
1 |
16,041
|
22,725
|
21,224
|
39,808
|
50,736
|
57,578
|
56,161
|
56,161
|
P/E ratio
|
12.4
x
|
13.5
x
|
12.9
x
|
15.2
x
|
15
x
|
17.5
x
|
15.9
x
|
14
x
|
Yield
|
2.49%
|
2.21%
|
2.33%
|
2.43%
|
2.18%
|
2.73%
|
3%
|
3.2%
|
Capitalization / Revenue
|
1.02
x
|
1.22
x
|
1.17
x
|
1.57
x
|
1.62
x
|
1.72
x
|
1.57
x
|
1.43
x
|
EV / Revenue
|
1.02
x
|
1.22
x
|
1.17
x
|
1.57
x
|
1.62
x
|
1.72
x
|
1.57
x
|
1.43
x
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EV / FCF
|
1,40,84,696
x
|
2,67,93,903
x
|
1,44,81,925
x
|
-11,78,29,832
x
|
-4,30,53,993
x
|
1,30,23,785
x
|
-
|
-
|
FCF Yield
|
0%
|
0%
|
0%
|
-0%
|
-0%
|
0%
|
-
|
-
|
Price to Book
|
0.77
x
|
0.94
x
|
0.85
x
|
1.2
x
|
1.32
x
|
1.23
x
|
1.15
x
|
1.1
x
|
Nbr of stocks (in thousands)
|
23,747
|
23,747
|
23,747
|
23,747
|
22,811
|
22,491
|
-
|
-
|
Reference price
2 |
1,204
|
1,495
|
1,499
|
2,218
|
2,616
|
2,497
|
2,497
|
2,497
|
Announcement Date
|
25/04/19
|
28/04/20
|
30/04/21
|
28/04/22
|
28/04/23
|
30/04/24
|
-
|
-
|
Fiscal Period: März |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
28,084
|
29,047
|
30,509
|
33,448
|
36,838
|
33,531
|
35,800
|
39,300
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
3,199
|
3,641
|
3,939
|
4,881
|
5,057
|
4,197
|
4,900
|
5,600
|
Operating Margin
|
11.39%
|
12.53%
|
12.91%
|
14.59%
|
13.73%
|
12.52%
|
13.69%
|
14.25%
|
Earnings before Tax (EBT)
1 |
3,452
|
3,810
|
4,021
|
5,017
|
5,643
|
4,867
|
5,250
|
5,950
|
Net income
1 |
2,303
|
2,621
|
2,758
|
3,472
|
4,079
|
3,327
|
3,550
|
4,050
|
Net margin
|
8.2%
|
9.02%
|
9.04%
|
10.38%
|
11.07%
|
9.92%
|
9.92%
|
10.31%
|
EPS
2 |
96.98
|
110.4
|
116.2
|
146.3
|
174.4
|
146.4
|
156.8
|
178.9
|
Free Cash Flow
|
2,030
|
1,325
|
2,458
|
-447
|
-1,386
|
4,421
|
-
|
-
|
FCF margin
|
7.23%
|
4.56%
|
8.06%
|
-1.34%
|
-3.76%
|
13.18%
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
88.15%
|
50.55%
|
89.12%
|
-
|
-
|
132.88%
|
-
|
-
|
Dividend per Share
2 |
30.00
|
33.00
|
35.00
|
54.00
|
57.00
|
70.00
|
75.00
|
80.00
|
Announcement Date
|
25/04/19
|
28/04/20
|
30/04/21
|
28/04/22
|
28/04/23
|
30/04/24
|
-
|
-
|
Fiscal Period: Marzo |
2020 S1
|
2021 S1
|
2022 S1
|
2022 Q3
|
2023 Q1
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2023 S2
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 Q4
|
2024 S2
|
---|
Net sales
1 |
14,274
|
14,400
|
16,218
|
8,571
|
9,442
|
18,677
|
9,085
|
9,076
|
18,161
|
8,104
|
8,075
|
16,179
|
8,123
|
9,229
|
17,352
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
1,654
|
1,880
|
2,387
|
1,369
|
1,497
|
2,727
|
1,390
|
940
|
2,330
|
1,057
|
903
|
1,960
|
1,003
|
1,234
|
2,237
|
Operating Margin
|
11.59%
|
13.06%
|
14.72%
|
15.97%
|
15.85%
|
14.6%
|
15.3%
|
10.36%
|
12.83%
|
13.04%
|
11.18%
|
12.11%
|
12.35%
|
13.37%
|
12.89%
|
Earnings before Tax (EBT)
|
1,726
|
1,914
|
2,473
|
1,457
|
1,623
|
2,882
|
1,732
|
-
|
-
|
1,191
|
-
|
2,126
|
1,163
|
-
|
-
|
Net income
|
1,176
|
1,315
|
1,698
|
984
|
1,096
|
1,956
|
1,196
|
-
|
-
|
834
|
-
|
1,499
|
799
|
-
|
-
|
Net margin
|
8.24%
|
9.13%
|
10.47%
|
11.48%
|
11.61%
|
10.47%
|
13.16%
|
-
|
-
|
10.29%
|
-
|
9.27%
|
9.84%
|
-
|
-
|
EPS
|
49.53
|
55.40
|
71.54
|
41.42
|
46.41
|
82.84
|
50.85
|
-
|
-
|
36.60
|
-
|
65.72
|
35.07
|
-
|
-
|
Dividend per Share
|
15.50
|
16.50
|
25.00
|
-
|
-
|
28.00
|
-
|
-
|
-
|
-
|
-
|
35.00
|
-
|
-
|
-
|
Announcement Date
|
30/10/19
|
28/10/20
|
28/10/21
|
27/01/22
|
28/07/22
|
28/10/22
|
30/01/23
|
28/04/23
|
28/04/23
|
28/07/23
|
30/10/23
|
30/10/23
|
30/01/24
|
30/04/24
|
30/04/24
|
Fiscal Period: Marzo |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
12,551
|
12,777
|
14,373
|
12,862
|
8,937
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
2,030
|
1,325
|
2,458
|
-447
|
-1,386
|
4,421
|
-
|
-
|
ROE (net income / shareholders' equity)
|
6.3%
|
7%
|
6.9%
|
8.1%
|
9.2%
|
7.2%
|
7.4%
|
8.1%
|
ROA (Net income/ Total Assets)
|
7.43%
|
8.19%
|
8.24%
|
9.49%
|
9.67%
|
7.67%
|
-
|
-
|
Assets
1 |
31,009
|
32,019
|
33,471
|
36,593
|
42,190
|
43,389
|
-
|
-
|
Book Value Per Share
2 |
1,562
|
1,590
|
1,774
|
1,852
|
1,985
|
2,074
|
2,169
|
2,273
|
Cash Flow per Share
|
144.0
|
161.0
|
161.0
|
191.0
|
215.0
|
210.0
|
-
|
-
|
Capex
1 |
1,404
|
1,736
|
2,240
|
2,732
|
2,825
|
1,857
|
3,000
|
3,000
|
Capex / Sales
|
5%
|
5.98%
|
7.34%
|
8.17%
|
7.67%
|
5.54%
|
8.38%
|
7.63%
|
Announcement Date
|
25/04/19
|
28/04/20
|
30/04/21
|
28/04/22
|
28/04/23
|
30/04/24
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| -16.66% | 361M | | +17.59% | 66.6B | | +0.84% | 48.75B | | +17.11% | 41.45B | | +22.26% | 26.74B | | +11.45% | 19.55B | | +5.08% | 18.21B | | -21.31% | 16.02B | | +4.43% | 15.62B | | -9.70% | 15.33B |
Other Specialty Chemicals
|